Dow Up 1.63% Nasdaq Up 0.97%

Celsion Corp. (CLSN)

-NasdaqCM
2.55 0.06(2.30%) Oct 17, 4:00PM EDT
Prev Close:2.61
Open:2.60
Bid:2.26 x 200
Ask:2.70 x 200
1y Target Est:8.00
Beta:1.85
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:2.51 - 2.68
52wk Range:2.38 - 5.90
Volume:91,898
Avg Vol (3m):103,418
Market Cap:50.89M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNDown 2.30%50.89M
BSDM16.67M
DCTH16.44M
MMSI543.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):104.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback